Cholesterol side-chain cleavage enzyme
CYP11A1 | |||
---|---|---|---|
Gene ontology | |||
Molecular function | |||
Cellular component | |||
Biological process |
| ||
Sources:Amigo / QuickGO |
Ensembl | |||||||||
---|---|---|---|---|---|---|---|---|---|
UniProt | |||||||||
RefSeq (mRNA) | |||||||||
RefSeq (protein) | |||||||||
Location (UCSC) | Chr 15: 74.34 – 74.37 Mb | Chr 9: 57.91 – 57.93 Mb | |||||||
PubMed search | [3] | [4] |
View/Edit Human | View/Edit Mouse |
Cholesterol side-chain cleavage enzyme is commonly referred to as P450scc, where "scc" is an acronym for
P450scc is a member of the cytochrome P450 superfamily of enzymes (family 11, subfamily A, polypeptide 1) and is encoded by the CYP11A1 gene.[6]
Nomenclature
cholesterol monooxygenase (side-chain-cleaving) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Identifiers | |||||||||
ExPASy | NiceZyme view | ||||||||
KEGG | KEGG entry | ||||||||
MetaCyc | metabolic pathway | ||||||||
PRIAM | profile | ||||||||
PDB structures | RCSB PDB PDBe PDBsum | ||||||||
Gene Ontology | AmiGO / QuickGO | ||||||||
|
The systematic name of this enzyme class is cholesterol, reduced-adrenal-ferredoxin:oxygen oxidoreductase (side-chain-cleaving). Other names include:
|
Tissue and intracellular localization
The highest level of the cholesterol side-chain cleavage system is found in the
Mechanism of action
P450scc
Each monooxygenase step requires 2
All three proteins together constitute the cholesterol side-chain cleavage complex.The involvement of three proteins in cholesterol side-chain cleavage reaction raises the question of whether the three proteins function as a ternary complex as reductase:adrenodoxin:P450. Both spectroscopic studies of adrenodoxin binding to P450scc and kinetic studies in the presence of varying concentrations of adrenodoxin reductase demonstrated that the reductase competes with P450scc for binding to adrenodoxin. These results demonstrated that the formation of a functional ternary complex is not possible.[17] From these studies, it was concluded that the binding sites of adrenodoxin to its reductase and to P450 are overlapping and, as a consequence, adrenodoxin functions as a mobile electron shuttle between reductase and P450.[17] These conclusions have been confirmed by structural analysis of adrenodoxin and P450 complex.[19]
The process of electron transfer from NADPH to P450scc is not tightly coupled; that is, during electron transfer from adrenodoxin reductase via adrenodoxin to P450scc, a certain portion of the electrons leak outside of the chain and react with O2, generating superoxide radicals.[20] Steroidogenic cells include a diverse array of antioxidant systems to cope with the radicals generated by the steroidogenic enzymes.[21]
Regulation
In each steroidogenic cell, the expression of the P450scc system proteins is regulated by the trophic hormonal system specific for the cell type.
P450scc is always active, however its activity is limited by the supply of cholesterol in the inner membrane. The supplying of cholesterol to this membrane (from the
Corticotropin (ACTH) is a hormone that is released from the anterior pituitary in response to stress situations. A study of the steroidogenic capacity of the adrenal cortex in infants with acute respiratory disease demonstrated that indeed during disease state there is a specific increase in the steroidogenic capacity for the synthesis of the glucocorticoid cortisol but not for the mineralocorticoid aldosterone or androgen DHEAS that are secreted from other zones of the adrenal cortex.[24]
Pathology
Mutations in the CYP11A1 gene result in a steroid hormone deficiency, causing a minority of cases of the rare and potentially fatal condition lipoid congenital adrenal hyperplasia.[25][26][27] Deficiency of CYP11A1 can result in hyperpigmentation, hypoglycemia, and recurrent infections.[28]
Inhibitors
Cholesterol side-chain cleavage enzyme inhibitors include aminoglutethimide, ketoconazole, and mitotane, among others.[29][30][31]
See also
- Steroidogenic enzyme
- Cytochrome P450 oxidase
References
- ^ a b c ENSG00000288362 GRCh38: Ensembl release 89: ENSG00000140459, ENSG00000288362 – Ensembl, May 2017
- ^ a b c GRCm38: Ensembl release 89: ENSMUSG00000032323 – Ensembl, May 2017
- ^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ^ S2CID 112729.
- ^ "Entrez Gene: CYP11A1 cytochrome P450, family 11, subfamily A, polypeptide 1".
- PMID 8788180.
- PMID 11720889.
- PMID 3011431.
- PMID 2170421.
- ^ PMID 2173715.
- ^ Topological studies of cytochromes P-450scc and P-45011 beta in bovine adrenocortical inner mitochondrial membranes. Effects of controlled tryptic digestion. J. Biol. Chem. 1979 254: 10443-8.
- PMID 3948785.
- PMID 6783659.
- PMID 7588385.
- PMID 3691502.
- ^ PMID 6766943.
- PMID 7217084.
- PMID 21636783.
- PMID 8396893.
- S2CID 10766948.
- ^ S2CID 5350278.
- PMID 17594537.
- S2CID 44439040.
- PMID 16639391.
- PMID 16705068.
- PMID 18182448.
- PMID 31610036.
- ISBN 978-0-7817-1750-2.
- ISBN 978-1-4557-1126-0.
- ISBN 978-3-319-12108-6.
Further reading
- Helmberg A (August 1993). "Twin genes and endocrine disease: CYP21 and CYP11B genes". Acta Endocrinologica. 129 (2): 97–108. PMID 8372604.
- Papadopoulos V, Amri H, Boujrad N, Cascio C, Culty M, Garnier M, et al. (January 1997). "Peripheral benzodiazepine receptor in cholesterol transport and steroidogenesis". Steroids. 62 (1): 21–28. S2CID 1977513.
- Stocco DM (June 2000). "Intramitochondrial cholesterol transfer". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1486 (1): 184–197. PMID 10856721.
- Kristensen VN, Kure EH, Erikstein B, Harada N, Børresen-Dale A (October 2001). "Genetic susceptibility and environmental estrogen-like compounds". Mutation Research. 482 (1–2): 77–82. PMID 11535251.
- Strauss JF (November 2003). "Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome". Annals of the New York Academy of Sciences. 997 (1): 42–48. S2CID 23559461.
- Wada A, Waterman MR (November 1992). "Identification by site-directed mutagenesis of two lysine residues in cholesterol side chain cleavage cytochrome P450 that are essential for adrenodoxin binding". The Journal of Biological Chemistry. 267 (32): 22877–22882. PMID 1429635.
- Hu MC, Guo IC, Lin JH, Chung BC (March 1991). "Regulated expression of cytochrome P-450scc (cholesterol-side-chain cleavage enzyme) in cultured cell lines detected by antibody against bacterially expressed human protein". The Biochemical Journal. 274 (Pt 3): 813–817. PMID 1849407.
- Sparkes RS, Klisak I, Miller WL (June 1991). "Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25". DNA and Cell Biology. 10 (5): 359–365. PMID 1863359.
- Coghlan VM, Vickery LE (October 1991). "Site-specific mutations in human ferredoxin that affect binding to ferredoxin reductase and cytochrome P450scc". The Journal of Biological Chemistry. 266 (28): 18606–18612. PMID 1917982.
- Matteson KJ, Chung BC, Urdea MS, Miller WL (April 1986). "Study of cholesterol side-chain cleavage (20,22 desmolase) deficiency causing congenital lipoid adrenal hyperplasia using bovine-sequence P450scc oligodeoxyribonucleotide probes". Endocrinology. 118 (4): 1296–1305. PMID 2419119.
- Chung BC, Matteson KJ, Voutilainen R, Mohandas TK, Miller WL (December 1986). "Human cholesterol side-chain cleavage enzyme, P450scc: cDNA cloning, assignment of the gene to chromosome 15, and expression in the placenta". Proceedings of the National Academy of Sciences of the United States of America. 83 (23): 8962–8966. PMID 3024157.
- Morohashi K, Sogawa K, Omura T, Fujii-Kuriyama Y (April 1987). "Gene structure of human cytochrome P-450(SCC), cholesterol desmolase". Journal of Biochemistry. 101 (4): 879–887. PMID 3038854.
- Maruyama K, Sugano S (January 1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–174. PMID 8125298.
- Gharani N, Waterworth DM, Batty S, White D, Gilling-Smith C, Conway GS, et al. (March 1997). "Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism". Human Molecular Genetics. 6 (3): 397–402. PMID 9147642.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, Suyama A, Sugano S (October 1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–156. PMID 9373149.
- Hukkanen J, Mäntylä M, Kangas L, Wirta P, Hakkola J, Paakki P, et al. (February 1998). "Expression of cytochrome P450 genes encoding enzymes active in the metabolism of tamoxifen in human uterine endometrium". Pharmacology & Toxicology. 82 (2): 93–97. PMID 9498238.
- Zhou Z, Shackleton CH, Pahwa S, White PC, Speiser PW (March 1998). "Prominent sex steroid metabolism in human lymphocytes". Molecular and Cellular Endocrinology. 138 (1–2): 61–69. S2CID 20490901.
Steroid hormone synthesis
Additional images
External links
- Cytochrome+P450scc at the U.S. National Library of Medicine Medical Subject Headings (MeSH)